Illumina's Early Deal Close Draws EU 'Interim Measures'
By Bryan Koenig ( September 20, 2021, 5:16 PM EDT) -- European Union antitrust officials moved Monday to punish Illumina with undisclosed "interim measures" over the DNA sequencing company's "unprecedented" decision to close its $8 billion reacquisition of cancer-testing outfit Grail while an investigation into the deal was still underway....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.